DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Gilead Sciences Canada, Inc. Mississauga. ON L5N 2W3, Product Monograph Pr ZYDELIG™ Idelalisib Tablets 150 mg/100 mg, 25 March 2015.
We do not assume any responsibility for the contents of the web pages of other providers.